Our results show that a cut-off of four newly emerged F-FDG-avid lesions on posttherapy PET/CT gives a reliable indication of treatment failure in patients under ipilimumab treatment. Moreover, the functional size of the new lesions plays an important role in predicting the clinical response. Validation of these results in larger cohorts of patients is warranted.

Arthralgia is frequent during PD1ab treatment. The clinical picture varies between synovitis of predominantly large joints, progressive osteoarthritis and arthralgia without evident joint damage. Vast majority of cases can be satisfactorily managed by NSAID and/or low-dose corticosteroids.

Cone beam computed tomography is an accurate means of measuring volume of artificially created bone cavities in an ex vivo model. This may provide a valuable tool for monitoring the healing rate of apical periodontitis; further investigations are warranted.